Results 21 to 30 of about 49,840 (301)

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. [PDF]

, 2016
ObjectivesTo examine the cost-effectiveness of primary debulking surgery (PDS) when compared to neoadjuvant chemotherapy (NACT) in the management of epithelial ovarian cancer (EOC) using Surveillance, Epidemiology, and End Results data linked to Medicare
Chang, Jenny, Forde, Gareth K, Ziogas, Argyrios   +2 more
core   +1 more source

Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. [PDF]

, 2017
Malignant mesothelioma is a rare cancer that arises from the mesothelial cells that line the pleural cavity and less commonly from the peritoneal lining of the abdomen and pelvis.
Bastian, Boris C, Chen, Yunn-Yi, Garg, Karuna, Joseph, Nancy M, Nasr, Anthony, Onodera, Courtney, Rabban, Joseph T, Solomon, David A, Talevich, Eric, Yeh, Iwei, Zaloudek, Charles   +10 more
core   +2 more sources

The Prognostic Impact of Pathology on Patients With Pseudomyxoma Peritonei Undergoing Debulking Surgery: A Systematic Review and Meta-Analysis of Retrospective Studies

Frontiers in Surgery, 2020
Background: Pseudomyxoma peritonei (PMP) is a rare clinical condition with fatal outcomes, which is characterized by the progressive accumulation of mucinous ascites and peritoneal implants. Some studies have reported the effect of PMP biology on patient
Shengnan Zhou, Huaiyu Zhao, Xiaodong He
doaj   +1 more source

Primary versus interval debulking surgery in the management of ovarian cancer patients, current data summary

Clinical and Experimental Obstetrics & Gynecology, 2022
Objective: Optimal management of ovarian cancer patients have been investigated by several centers and have been discussed in a great number of published articles.
Victoria Psomiadou, Alexandros Fotiou, Christos Iavazzo   +2 more
doaj   +1 more source

DNA-Based Liquid Biopsy for Evaluating Surgical and Postsurgical Outcomes in Gynecologic Malignancies: A Systematic Review. [PDF]

J Clin Lab Anal
Liquid biopsy using plasma and uterine aspirate samples provides a minimally invasive tool for detecting and monitoring gynecologic cancers. Circulating tumor DNA (ctDNA) and cell‐free DNA (cfDNA) enable prognosis, treatment response assessment, and improved diagnostic accuracy across various tumor types. ABSTRACT Introduction DNA‐based liquid biopsies,
Yavari S, Javankiani S, Yarahmadi F, Sarallah R, Rezaei B, Maroufi M, Amlashi MK, Imankhan M, Marvi M, Aslani N, Soltanattar A, Mohammadi Z, Azani A, Kavousinia P.   +13 more
europepmc   +2 more sources

Principles of Pituitary Surgery [PDF]

, 2018
Key Points 1. Understand the principles of pituitary surgery including the key-elements of surgical planning and decision-making 2. Identify the technical nuances distinguishing the endoscopic from the microscopic transsphenoidal approach 3.
Evans, James J., Farag, MD, Alexander, Farrell, MD, Christopher J, Nyquist, MD, Gurston G., Rosen, Marc, MD   +4 more
core   +2 more sources

Role of debulking mucoid ACL in unicompartmental knee arthroplasty: a prospective multicentric study

Knee Surgery & Related Research, 2022
Background Mucoid degeneration of the anterior cruciate ligament (ACL) has been shown to cause restricted terminal range of motion and rest pain. If present in a patient undergoing unicompartmental knee arthroplasty, it can deteriorate the final outcome.
Amyn M. Rajani, Urvil A. Shah, Anmol R. S. Mittal, Sheetal Gupta, Rajesh Garg, Meenakshi Punamiya   +5 more
doaj   +1 more source

Power-assisted Liposuction for Lymphedema: A Cost-utility Analysis

Plastic and Reconstructive Surgery, Global Open, 2022
Background:. Lymphedema is a chronic, debilitating disease that has been described as the largest breast cancer survivorship burden. Debulking surgery has been shown to improve extremity volume, improve patient quality of life, and decrease the incidence
Joshua A. Bloom, MD, Melisa Granoff, BA, Tobias Karlsson, MD, Arin K. Greene, MD, MMSc, Håkan Brorson, MD, PhD, Abhishek Chatterjee, MD, MBA, Dhruv Singhal, MD   +6 more
doaj   +1 more source

The next steps in improving the outcomes of advanced ovarian cancer [PDF]

, 2015
Worldwide ovarian cancer affects over 200,000 women per year. Overall survival rates are poor due to two predominate reasons. First, the majority of patients present with advanced disease creating significant difficulty with effecting disease eradication.
Blagden, S, Fotopoulou, C, Gabra, H, Openshaw, MR   +3 more
core   +1 more source

A comparison between primary debulking surgery and primary chemotherapy in patients with advanced ovarian cancer: a retrospective study

Al-Azhar Assiut Medical Journal, 2018
Background Early detection of ovarian cancer is troublesome owing to the obscurity of conspicuous clinical symptoms. Hence, 75% of patients with ovarian cancer usually present and are diagnosed at an advanced stage (International Federation of Gynecology
Mohamed Esmat, Mohamed Ashour
doaj   +1 more source